Crédit Industriel et Commercial’s Avidity Biosciences RNAM Stock Holding History

Crédit Industriel et Commercial’s Portfolio RNAM Stock Details RNAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-168,000	Closed	-$12.1M	–	427
2025 Q4	$12.1M	Buy	+168,000	New	+$10.9M	0.93%	25

Other funds holding RNAM

Corsicana & Co Corsicana, Texas $206M AUM 26.42% 1-Year Est. Return

Crédit Industriel et Commercial's RNAM Position: Q1 2026 in Review

Crédit Industriel et Commercial sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 168,000 shares — an estimated $12.1M sold.

Crédit Industriel et Commercial first reported a position in RNAM in Q4 2025 and held it in 1 quarter. The position peaked at $12.1M in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

Crédit Industriel et Commercial reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
Crédit Industriel et Commercial sold 168,000 Avidity Biosciences shares in Q1 2026, an estimated $12.1M.
Crédit Industriel et Commercial first reported a position in Avidity Biosciences in Q4 2025 and held it in 1 quarter.
Crédit Industriel et Commercial's Avidity Biosciences position peaked at $12.1M in Q4 2025.
1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Crédit Industriel et Commercial's 13F filing for Q1 2026, filed 29 Apr 2026.